tiprankstipranks
Xoma Corp (XOMA)
NASDAQ:XOMA

Xoma Stock Price & Analysis

308 Followers

XOMA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$15.68 - $32.09
Previous Close$17.29
Volume5.43K
Average Volume (3M)37.05K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$45.73M
Total Debt (Recent Filing)$133.00K
P/E Ratio57.0
Beta1.28
Next EarningsNov 09, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)0.30
Shares Outstanding11,450,823
R-Squared0.06
Standard Deviation0.19
10 Day Avg. Volume21,066
30 Day Avg. Volume37,050
P/B Ratio1.52
P/S Ratio4.87
P/CF Ratio9.90
P/FCF Ratio20.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside299.07% Upside
Rating ConsensusModerate Buy
Alpha0.00833
Number of Analyst Covering1


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

XOMA FAQ

What was Xoma’s price range in the past 12 months?
Xoma lowest stock price was $15.68 and its highest was $32.09 in the past 12 months.
    What is Xoma’s market cap?
    Currently, no data Available
    When is Xoma’s upcoming earnings report date?
    Xoma’s upcoming earnings report date is Nov 09, 2022 which is in 35 days.
      How were Xoma’s earnings last quarter?
      Xoma released its earnings results on Aug 04, 2022. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.163 by -$0.367.
        Is Xoma overvalued?
        According to Wall Street analysts Xoma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Xoma pay dividends?
          Xoma does not currently pay dividends.
          What is Xoma’s EPS estimate?
          Xoma’s EPS estimate is -$0.23.
            How many shares outstanding does Xoma have?
            Xoma has 11,450,823 shares outstanding.
              What happened to Xoma’s price movement after its last earnings report?
              Xoma reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.163. Following the earnings report the stock price went down -6.642%.
                Which hedge fund is a major shareholder of Xoma?
                Currently, no hedge funds are holding shares in XOMA

                ---

                Xoma Stock Analysis

                Smart ScoreNeutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                7
                The Xoma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Xoma Corp

                XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                AbbVie
                Amgen
                Gilead Sciences
                Moderna
                Vertex Pharmaceuticals

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis